1921
Volume 102, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Dengue is the most common mosquito-borne flaviviral infection in the world today. Several factors contribute and act synergistically to cause severe infection. One of these is dysregulated host immunological mediators that cause transient pathophysiology during infection. These mediators act on the endothelium to increase vascular permeability, which leads to plasma leakage compromising hemodynamics and coagulopathy. We conducted a prospective study to explore the expression of pro- and anti-inflammatory cytokines and how they relate to clinical dengue manifestations, by assessing their dynamics through acute dengue infection in adults admitted to the Hospital for Tropical Diseases, Bangkok, Thailand. We performed cytokine analysis at three phases of infection for 96 hospitalized adults together with serotyping of confirmed dengue infection during the outbreaks of 2015 and 2016. The serum concentrations of seven cytokines (interleukin [IL]-2, IL-4, IL-6, IL-8, IL-10, tumor necrosis factor alpha, and interferon gamma) were measured in duplicate using a commercial kit (Bio-Plex Human Cytokine Assay). In this study, the cytokine profile was suggestive of a T-helper 2 response. Most patients had secondary infection, and the levels of viremia were higher in patients with plasma leakage than those without plasma leakage. In addition, we observed that bleeding and hepatitis were associated with significantly higher levels of IL-8 during the early phases of infection. Furthermore, IL-6 levels in the early phase of infection were also elevated in bleeding patients with plasma leakage. These results suggest that IL-6 and IL-8 may act in synergy to cause bleeding in patients with plasma leakage.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0487
2020-03-02
2020-06-06
Loading full text...

Full text loading...

/deliver/fulltext/14761645/102/5/tpmd190487.html?itemId=/content/journals/10.4269/ajtmh.19-0487&mimeType=html&fmt=ahah

References

  1. Gubler DJ, 2011. Dengue, urbanization and globalization: the unholy trinity of the 21(st) century. Trop Med Health 39 (Suppl 4): 311.
    [Google Scholar]
  2. Lauer SA et al., 2018. Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010–2014. Proc Natl Acad Sci USA 115: E2175E2182.
    [Google Scholar]
  3. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM, 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63: 7175.
    [Google Scholar]
  4. Suksanpaisan L, Cabrera-Hernandez A, Smith DR, 2007. Infection of human primary hepatocytes with dengue virus serotype 2. J Med Virol 79: 300307.
    [Google Scholar]
  5. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman AL, 2002. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 76: 55885597.
    [Google Scholar]
  6. Vervaeke P, Vermeire K, Liekens S, 2015. Endothelial dysfunction in dengue virus pathology. Rev Med virol 25: 5067.
    [Google Scholar]
  7. Chunhakan S, Butthep P, Yoksan S, Tangnararatchakit K, Chuansumrit A, 2015. Vascular leakage in dengue hemorrhagic fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production. Int J Vasc Med 2015: 917143.
    [Google Scholar]
  8. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS, 2000. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183188.
    [Google Scholar]
  9. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM, 2010. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10: 712722.
    [Google Scholar]
  10. Inyoo S, Suttitheptumrong A, Pattanakitsakul SN, 2017. Synergistic effect of TNF-alpha and dengue virus infection on adhesion molecule reorganization in human endothelial cells. Jpn J Infect Dis 70: 186191.
    [Google Scholar]
  11. Thanachartwet V, Oer-Areemitr N, Chamnanchanunt S, Sahassananda D, Jittmittraphap A, Suwannakudt P, Desakorn V, Wattanathum A, 2015. Identification of clinical factors associated with severe dengue among Thai adults: a prospective study. BMC Infect Dis 15: 420.
    [Google Scholar]
  12. Samanta J, Sharma V, 2015. Dengue and its effects on liver. World J Clin Cases 3: 125131.
    [Google Scholar]
  13. Rajapakse S, de Silva NL, Weeratunga P, Rodrigo C, Fernando SD, 2017. Prophylactic and therapeutic interventions for bleeding in dengue: a systematic review. Trans R Soc Trop Med Hyg 111: 433439.
    [Google Scholar]
  14. Treeprasertsuk S, Kittitrakul C, 2015. Liver complications in adult dengue and current management. Southeast Asian J Trop Med Public Health 46 (Suppl 1): 99107.
    [Google Scholar]
  15. de Azeredo EL, Monteiro RQ, de-Oliveira Pinto LM, 2015. Thrombocytopenia in dengue: interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediators Inflamm 2015: 313842.
    [Google Scholar]
  16. Medin CL, Fitzgerald KA, Rothman AL, 2005. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J Virol 79: 1105311061.
    [Google Scholar]
  17. Raghupathy R et al., 1998;Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 56: 280285.
    [Google Scholar]
  18. Nagila A, Netsawang J, Suttitheptumrong A, Morchang A, Khunchai S, Srisawat C, Puttikhunt C, Noisakran S, Yenchitsomanus PT, Limjindaporn T, 2013. Inhibition of p38MAPK and CD137 signaling reduce dengue virus-induced TNF-alpha secretion and apoptosis. Virol J 10: 105.
    [Google Scholar]
  19. Sehrawat P, Biswas A, Kumar P, Singla P, Wig N, Dar L, Sood R, 2018. Role of cytokines as molecular marker of dengue severity. Mediterr J Hematol Infect Dis 10: e2018023.
    [Google Scholar]
  20. Shu PY, Chang SF, Kuo YC, Yueh YY, Chien LJ, Sue CL, Lin TH, Huang JH, 2003. Development of group- and serotype-specific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J Clin Microbiol 41: 24082416.
    [Google Scholar]
  21. Wang WK, Lee CN, Kao CL, Lin YL, King CC, 2000. Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNA. J Clin Microbiol 38: 33063310.
    [Google Scholar]
  22. Lin CY, Huang CH, Chen YH, 2013. Classification of dengue: the clinical use of World Health Organization 2009 guideline. J Formos Med Assoc 112: 6163.
    [Google Scholar]
  23. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A, 2003. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 100: 1433314338.
    [Google Scholar]
  24. Silverman RH, 2007. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81: 1272012729.
    [Google Scholar]
  25. Chakravarti A, Kumaria R, 2006;Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res 123: 2530.
    [Google Scholar]
  26. Morrison J, Aguirre S, Fernandez-Sesma A, 2012. Innate immunity evasion by dengue virus. Viruses 4: 397413.
    [Google Scholar]
  27. Maneekan P, Leaungwutiwong P, Misse D, Luplertlop N, 2013. T helper (Th) 1 and Th2 cytokine expression profile in dengue and malaria infection using magnetic bead-based bio-plex assay. Southeast Asian J Trop Med Public Health 44: 3136.
    [Google Scholar]
  28. Malavige GN, Gomes L, Alles L, Chang T, Salimi M, Fernando S, Nanayakkara KD, Jayaratne S, Ogg GS, Serum IL-10 as a marker of severe dengue infection. BMC Infect Dis 2013;13: 341.
    [Google Scholar]
  29. Couper KN, Blount DG, Riley EM, 2008. IL-10: the master regulator of immunity to infection. J Immunol 180: 57715777.
    [Google Scholar]
  30. Abhishek KS, Chakravarti A, Baveja CP, Kumar N, Siddiqui O, Kumar S, 2017. Association of interleukin-2, -4 and -10 with dengue severity. Indian J Pathol Microbiol 60: 6669.
    [Google Scholar]
  31. Vaughn DW et al., 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 29.
    [Google Scholar]
  32. Iani FC, Caldas S, Duarte MM, Cury AL, Cecílio AB, Costa PA, Antonelli LR, Gollob KJ, 2016. Dengue patients with early hemorrhagic manifestations lose coordinate expression of the anti-inflammatory cytokine IL-10 with the inflammatory cytokines IL-6 and IL-8. Am J Trop Med Hyg 95: 193200.
    [Google Scholar]
  33. Cruz Hernandez SI, Puerta-Guardo HN, Flores Aguilar H, González Mateos S, López Martinez I, Ortiz-Navarrete V, Ludert JE, Angel RM, 2016. Primary dengue virus infections induce differential cytokine production in Mexican patients. Mem Inst Oswaldo Cruz 111: 161167.
    [Google Scholar]
  34. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, Mokashi N, Vaidya D, Shah PS, Cecilia D, 2010, Clinical findings and pro-inflammatory cytokines in dengue patients in western India: a facility-based study. PLoS One 5: e8709.
    [Google Scholar]
  35. Pinto LM, Oliveira SA, Braga EL, Nogueira RM, Kubelka CF, 1999. Increased pro-inflammatory cytokines (TNF-alpha and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever. Mem Inst Oswaldo Cruz 94: 387394.
    [Google Scholar]
  36. Rothman AL, Ennis FA, 1999. Immunopathogenesis of dengue hemorrhagic fever. Virol 257: 16.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0487
Loading
/content/journals/10.4269/ajtmh.19-0487
Loading

Data & Media loading...

  • Received : 28 Jun 2019
  • Accepted : 19 Jan 2020
  • Published online : 02 Mar 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error